CH-4987655 | Interleukin Related interleukin-related.com

Product Name :
CH-4987655

Search keywords :
RO4987655

drugId :
null

Target Vo:
Dual specificity mitogen-activated protein kinase kinase 1

Target Vo Short Name :
MEK1

Moa_Name:
Dual specificity mitogen-activated protein kinase kinase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Chugai Pharmaceutical Co Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Neoplasms

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD11b Antibody
Aquaporin 5 Antibody
AIF Antibody (YA835): AIF Antibody (YA835) is a non-conjugated and Mouse origined monoclonal antibody about 67 kDa, targeting to AIF (8H1). It can be used for WB,ICC/IF assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts